Determination of oxcarbazepine and its related substances using UHPLC method with UV detection

Determination of oxcarbazepine and its related substances using UHPLC method with UV detection

A simple and rapid ultra - high performance liquid chromatographic (UHPLC) method for the separation and determination of oxcarbazepine and its related substances in tablets, was developed. Chromatographic separation of oxcarbazepine from its related substances (degradation and by-products) was achi...

Full description

Bibliographic Details
Main Authors:	Žirojević Jelena, Drljevic-Đurić Katica, Đurđević Aleksandra
Format:	Article
Language:	srp
Published:	Pharmaceutical Association of Serbia, Belgrade, Serbia 2014-01-01
Series:	Arhiv za farmaciju
Subjects:	oxcarbazepine related substances uhplc method gradient elution
Online Access:	https://scindeks-clanci.ceon.rs/data/pdf/0004-1963/2014/0004-19631402083Z.pdf

Similar Items

Oxcarbazepine and Hyponatremia
by: Julija Čiauškaitė, et al.
Published: (2022-04-01)

Related substance determination of formononetin by HPLC
by: Xingyan PAN, et al.
Published: (2017-02-01)

Nistagmus Downbeat Nystagmus Due to Oxcarbazepine Intoxication
by: Gül Yalçın Çakmaklı, et al.
Published: (2009-09-01)

Oxcarbazepine for refractory epilepsy: systematic review of the literature
by: Humberto Saconato, et al.

Hyponatremia from oxcarbazepine: A case report
by: P. Coucheiro Limeres, et al.
Published: (2022-06-01)

Oxcarbazepine-induced hyponatremia: A case report
by: M. Barbosa Pinto, et al.
Published: (2021-04-01)

Oxcarbazepine Therapy for Complete Central Diabetes Insipidus
by: Basmah Abdallah, et al.
Published: (2018-01-01)

Oxcarbazepine: Drug of the future in the treatment of trigeminal neuralgia
by: Revant H Chole, et al.
Published: (2011-01-01)

Oxcarbazepine Induced Maculopapular Rash - A Case Report
by: Arunava Biswas, et al.
Published: (2015-01-01)

Status epilepticus induced by hyponatremia as an adverse reaction to oxcarbazepine – case report
by: Corina Roman-Filip, et al.
Published: (2012-12-01)

Hepatitis C-related cryoglobulinemic neuropathy: potential role of oxcarbazepine for pain control
by: Rita Moretti, et al.
Published: (2018-01-01)

Reintroduction of oxcarbazepine after allergic reaction in two pediatric patients with epilepsy
by: Lingyan Yu, et al.
Published: (2021-08-01)

Development and validation of an improved HPLC-UV method for simultaneous determination of lamotrigine and oxcarbazepine and its active metabolite 10,11-dihydro-10-hydroxycarbazepine in human blood plasma and comparison with an UHPLC-MS/MS method
by: Siyao Jin, et al.
Published: (2019-12-01)

Efficacy and safety of oxcarbazepine in the treatment of children with epilepsy: a meta-analysis of randomized controlled trials
by: Geng H, et al.
Published: (2017-03-01)

Oxcarbazepine-induced syndrome of inappropriate antidiuretic hormone secretion in a trigeminal neuralgia: A case report
by: Swathi Mallikarjuna, et al.
Published: (2023-01-01)

Levetiracetam versus Oxcarbazepine as monotherapy in newly diagnosed focal epilepsy: A systematic review and meta‐analysis
by: Sanjeev Kharel, et al.
Published: (2022-11-01)

A Comparative Study between Oxcarbazepine and Gabapentin Regarding Therapeutic Efficiency and Tolerability in the Treatment of Trigeminal Neuralgia
by: Fakir Mohan Debta, et al.
Published: (2010-01-01)

Development and validation of indirect visible spectrophotometric methods for oxcarbazepine in pure and the tablet dosage form
by: Hemavathi N. Deepakumari, et al.
Published: (2016-09-01)

Effect of Penetration Enhancers on Transdermal Delivery of Oxcarbazepine, an Antiepileptic Drug Using Microemulsions
by: Amitkumar Virani, et al.
Published: (2023-01-01)

A Structurally Diverse Heterocyclic Library by Decoration of Oxcarbazepine Scaffold
by: Giovanni Palmisano, et al.
Published: (2013-11-01)

Randomized trial of betahistine mesilate tablets as augmentation for oxcarbazepine and carbamazepine in treating vestibular paroxysmia
by: Xue H, et al.
Published: (2018-04-01)

Oxcarbazepine: validation and application of an analytical method
by: Paula Cristina Rezende Enéas, et al.
Published: (2010-06-01)

Oxcarbazepine as the initial monotherapy of focal epilepsy in adolescents and adults
by: T. N. Pushkar, et al.
Published: (2021-06-01)

Efficacy and safety of levetiracetam vs. oxcarbazepine in the treatment of children with epilepsy: a systematic review and meta-analysis
by: Yuanyuan Liu, et al.
Published: (2024-04-01)

Effectiveness and Safety of Oxcarbazepine vs. Levetiracetam as Monotherapy for Infantile Focal Epilepsy: A Longitudinal Cohort Study
by: Binyang Zhao, et al.
Published: (2022-06-01)

Oxcarbazepine for Behavioral Disorders after Brain Injury: Factors Influencing Efficacy
by: Marco Pozzi, et al.
Published: (2021-07-01)

Association of oxcarbazepine concentration with seizure frequency in pregnant women with epilepsy
by: Lin-yan Wei, et al.
Published: (2024-01-01)

Oxcarbazepine-induced Stevens Johnson syndrome: A rare case report
by: S R Sharma, et al.
Published: (2011-01-01)

Application of Physiologically Based Pharmacokinetic Modeling to Predict Maternal Pharmacokinetics and Fetal Exposure to Oxcarbazepine
by: Lixia He, et al.
Published: (2022-11-01)

Comparison of Lamotrigine and Oxcarbazepine Monotherapy Among Chinese Adult Patients With Newly-Diagnosed Focal-Onset Epilepsy: A Prospective Observational Study
by: Yuncan Chen, et al.
Published: (2022-06-01)

Validation of a method for the quantitative determination of narcotic and psychotropic substances in urine by UHPLC–MS/MS
by: N. B. Savelieva, et al.
Published: (2022-07-01)

Predicted Efficacy of Once-Daily Extended-Release Oxcarbazepine (Oxtellar XR®) Monotherapy in Adults and Children with Partial-Onset Seizures: Exposure-Response Modeling and Simulation
by: Faison S, et al.
Published: (2020-09-01)

Compared to oxcarbazepine and carbamazepine, botulinum toxin type A is a useful therapeutic option for trigeminal neuralgia symptoms: A systematic review
by: Yeganeh Naderi, et al.
Published: (2024-04-01)

From the Streets to the Judicial Evidence: Determination of Traditional Illicit Substances in Drug Seizures by a Rapid and Sensitive UHPLC-MS/MS-Based Platform
by: Fabio Gosetti, et al.
Published: (2022-12-01)

Comparison of the effectiveness and safety of perampanel and oxcarbazepine as monotherapy in children and adolescents with newly diagnosed focal epilepsy
by: Jia-Qin Yi, et al.
Published: (2023-08-01)

Effectiveness of clozapine, oxcarbazepine and rivastigmine combination in a bipolar disorder patient with initial cerebral atrophy
by: Paolo Morana, et al.
Published: (2020-02-01)

Oxcarbazepine-induced stevens johnson syndrome and toxic epidermal necrolysis overlap
by: Sangha Mitra Godi, et al.
Published: (2022-01-01)

Corrigendum: Comparison of the effectiveness and safety of perampanel and oxcarbazepine as monotherapy in children and adolescents with newly diagnosed focal epilepsy
by: Jia-Qin Yi, et al.
Published: (2023-09-01)

Determination by UHPLC – UV – MS of polyphenol content of Amaranthus retroflexus
by: Aida P. SĂRĂCIN, et al.
Published: (2023-03-01)

Epileptiform activity index for assessing oxcarbazepin therapy of newly-diagnosed focal epilepsy in adolescents and adults
by: V. A. Karlov, et al.
Published: (2020-11-01)